Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.950
-0.320 (-7.49%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Perspective Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 | 2021 - 2017 |
| Net Income | -103.12 | -79.28 | -46.51 | -10.76 | -7.27 | Upgrade
|
| Depreciation & Amortization | 3.24 | 2.3 | 0.71 | 0.32 | 0.28 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0.01 | 0 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.03 | 0.02 | 0.31 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 24.06 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -2.72 | -0.61 | - | - | - | Upgrade
|
| Stock-Based Compensation | 8.97 | 5.22 | 3.14 | 0.98 | 1.09 | Upgrade
|
| Other Operating Activities | 9.46 | -2.06 | -2.24 | -0.22 | 0 | Upgrade
|
| Change in Accounts Receivable | 0.11 | 1.05 | 0.2 | 0.28 | 0.41 | Upgrade
|
| Change in Inventory | - | - | - | -2 | -2.67 | Upgrade
|
| Change in Accounts Payable | 0.15 | 1.89 | 1.57 | 0.69 | 0.24 | Upgrade
|
| Change in Unearned Revenue | -1.4 | 28 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 2.82 | 0.86 | 0.79 | -0.03 | 0.18 | Upgrade
|
| Operating Cash Flow | -82.48 | -18.29 | -36.91 | -10.4 | -7.71 | Upgrade
|
| Capital Expenditures | -12.75 | -54.41 | -1.07 | -0.28 | -0.27 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.34 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | 2.7 | - | - | Upgrade
|
| Investment in Securities | 54.11 | -164.78 | 22.76 | -22.69 | - | Upgrade
|
| Other Investing Activities | -0.14 | -0.07 | -0.02 | -6.02 | -0.02 | Upgrade
|
| Investing Cash Flow | 41.23 | -218.93 | 24.37 | -28.99 | -0.28 | Upgrade
|
| Long-Term Debt Repaid | -0.05 | -0.05 | -0.07 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.05 | -0.05 | -0.07 | - | - | Upgrade
|
| Issuance of Common Stock | 10.36 | 289.43 | 0.92 | 0.03 | 0.06 | Upgrade
|
| Other Financing Activities | - | - | -0.07 | - | - | Upgrade
|
| Financing Cash Flow | 10.31 | 289.39 | 0.79 | 0.03 | 0.06 | Upgrade
|
| Net Cash Flow | -30.95 | 52.16 | -11.76 | -39.36 | -7.94 | Upgrade
|
| Free Cash Flow | -95.23 | -72.71 | -37.99 | -10.68 | -7.98 | Upgrade
|
| Free Cash Flow Margin | -10772.96% | -5000.55% | -2648.88% | -197.28% | - | Upgrade
|
| Free Cash Flow Per Share | -1.29 | -1.13 | -1.42 | -0.75 | -0.56 | Upgrade
|
| Levered Free Cash Flow | -60.37 | -83.66 | -8.54 | - | -2.73 | Upgrade
|
| Unlevered Free Cash Flow | -60.14 | -83.63 | -8.49 | - | -2.73 | Upgrade
|
| Change in Working Capital | 1.68 | 31.8 | 2.56 | -1.05 | -1.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.